Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Cash from Operations: 2020-2024

Historic Cash from Operations for iSpecimen (ISPC) over the last 5 years, with Dec 2024 value amounting to -$8.3 million.

  • iSpecimen's Cash from Operations fell 88.58% to -$2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.9 million, marking a year-over-year decrease of 58.69%. This contributed to the annual value of -$8.3 million for FY2024, which is 42.29% down from last year.
  • Per iSpecimen's latest filing, its Cash from Operations stood at -$8.3 million for FY2024, which was down 42.29% from -$5.8 million recorded in FY2023.
  • In the past 5 years, iSpecimen's Cash from Operations ranged from a high of -$288,380 in FY2020 and a low of -$10.7 million during FY2021.
  • Moreover, its 3-year median value for Cash from Operations was -$5.8 million (2022), whereas its average is -$6.6 million.
  • Its Cash from Operations has fluctuated over the past 5 years, first tumbled by 3,599.43% in 2021, then soared by 45.47% in 2022.
  • Yearly analysis of 5 years shows iSpecimen's Cash from Operations stood at -$288,380 in 2020, then slumped by 3,599.43% to -$10.7 million in 2021, then spiked by 45.47% to -$5.8 million in 2022, then increased by 0.17% to -$5.8 million in 2023, then plummeted by 42.29% to -$8.3 million in 2024.